Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine

被引：7
作者：
Hlaca, Nika [1 ,2 ]
Zagar, Tina [1 ,2 ]
Kastelan, Marija [1 ,2 ]
Peternel, Sandra [1 ,2 ]
Brajac, Ines [1 ,2 ]
Dujmovic-Hasanbegovic, Katarina [1 ,2 ]
Prpic-Massari, Larisa [1 ,2 ]
机构：
[1] Clin Hosp Ctr Rijeka, Dept Dermatovenerol, Rijeka, Croatia
[2] Univ Rijeka, Fac Med, Rijeka, Croatia
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 11期
关键词：
D O I：
10.1111/dth.15791
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience
    Avallone, G.
    Cavallo, F.
    Astrua, C.
    Caldarola, G.
    Conforti, C.
    De Simone, C.
    di Meo, N.
    di Stefani, A.
    Genovese, G.
    Maronese, C. A.
    Marzano, A. V.
    Parente, R.
    Quaglino, P.
    Roccuzzo, G.
    Tassone, F.
    Zalaudek, I.
    Senetta, R.
    Ribero, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : E876 - E879
  • [2] Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin
    Criado, P. R.
    Ianhez, M.
    Rocha, P. S.
    Miot, H. A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : E508 - E510
  • [3] Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine
    Hunjan, M. K.
    Roberts, C.
    Karim, S.
    Hague, J.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (01) : 188 - 190
  • [4] Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine
    Llado, I.
    Butron, B.
    Sampedro-Ruiz, R.
    Fraga, J.
    deArgila, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : E833 - E835
  • [5] Mohamed Mariem, 2015, Indian J Dermatol Venereol Leprol, V81, P618, DOI 10.4103/0378-6323.168326
  • [6] Cutaneous reactions following booster dose administration of COVID-19 mRNA vaccine: A first look from the American Academy of Dermatology/International League of Dermatologic Societies registry
    Prasad, Sonya
    Mcmahon, Devon E.
    Tyagi, Anisha
    Ali, Rowanne
    Singh, Rhea
    Rosenbach, Misha
    Lim, Henry W.
    Fox, Lindy P.
    Blumenthal, Kimberly
    Hruza, GeorgeJ.
    French, Lars E.
    Freeman, Esther E.
    [J]. JAAD INTERNATIONAL, 2022, 8 : 49 - 51
  • [7] An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris
    Sahni, Mukesh Kumar
    Roy, Kanika
    Asati, Dinesh Prasad
    Khurana, Ujjawal
    [J]. INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2021, 32 (04) : 261 - 264
  • [8] Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine
    Sechi, A.
    Pierobon, E.
    Pezzolo, E.
    Germi, L.
    Trevisan, G.
    Zardo, D.
    Riva, G.
    Mondino, S.
    Naldi, L.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (02) : 437 - 440
  • [9] A Review on Pityriasis Rubra Pilaris
    Wang, Dingyuan
    Chong, Vanessa Cui-Lian
    Chong, Wei-Sheng
    Oon, Hazel H.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (03) : 377 - 390
1